Literature DB >> 15364098

Virulence regulation in Staphylococcus aureus: the need for in vivo analysis of virulence factor regulation.

Alexa A Pragman1, Patrick M Schlievert.   

Abstract

Staphylococcus aureus is a pathogenic microorganism that is responsible for a wide variety of clinical infections. These infections can be relatively mild, but serious, life-threatening infections may result from the expression of staphylococcal virulence factors that are coordinated by virulence regulators. Much work has been done to characterize the actions of staphylococcal virulence regulators in broth culture. Recently, several laboratories showed that transcriptional analyses of virulence regulators in in vivo animal models or in human infection did not correlate with transcriptional analyses accomplished in vitro. In describing the differences between in vitro and in vivo transcription of staphylococcal virulence regulators, we hope to encourage investigators to study virulence regulators using infection models whenever possible.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15364098     DOI: 10.1016/j.femsim.2004.05.005

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  40 in total

1.  Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus in Germany associated with travel or foreign family origin.

Authors:  J Maier; H Melzl; U Reischl; I Drubel; W Witte; N Lehn; H Linde
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-09       Impact factor: 3.267

2.  Rapid detection of Panton-Valentine leukocidin-positive Staphylococcus aureus by real-time PCR targeting the lukS-PV gene.

Authors:  U Reischl; M J Tuohy; G S Hall; G W Procop; N Lehn; H Linde
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-02       Impact factor: 3.267

3.  Sequence analysis of the Staphylococcus aureus srrAB loci reveals that truncation of srrA affects growth and virulence factor expression.

Authors:  Alexa A Pragman; Lisa Herron-Olson; Laura C Case; Sara M Vetter; Evan E Henke; Vivek Kapur; Patrick M Schlievert
Journal:  J Bacteriol       Date:  2007-08-10       Impact factor: 3.490

4.  Outcome for invasive Staphylococcus aureus infections.

Authors:  G Jacobsson; E Gustafsson; R Andersson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-01       Impact factor: 3.267

5.  Antivirulence potential of TR-700 and clindamycin on clinical isolates of Staphylococcus aureus producing phenol-soluble modulins.

Authors:  Jason Yamaki; Timothy Synold; Annie Wong-Beringer
Journal:  Antimicrob Agents Chemother       Date:  2011-06-13       Impact factor: 5.191

6.  Chitosan malate inhibits growth and exotoxin production of toxic shock syndrome-inducing Staphylococcus aureus strains and group A streptococci.

Authors:  Patrick M Schlievert
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

7.  Detection and measurement of staphylococcal enterotoxin-like K (SEl-K) secretion by Staphylococcus aureus clinical isolates.

Authors:  Jorge L Aguilar; Avanish K Varshney; Xiaobo Wang; Lindsay Stanford; Matthew Scharff; Bettina C Fries
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948

8.  Proteomic and transcriptomic profiling of Staphylococcus aureus surface LPXTG-proteins: correlation with agr genotypes and adherence phenotypes.

Authors:  Mathilde Ythier; Grégory Resch; Patrice Waridel; Alexandre Panchaud; Aurélie Gfeller; Paul Majcherczyk; Manfredo Quadroni; Philippe Moreillon
Journal:  Mol Cell Proteomics       Date:  2012-07-25       Impact factor: 5.911

9.  Colostrum hexasaccharide, a novel Staphylococcus aureus quorum-sensing inhibitor.

Authors:  A Srivastava; B N Singh; D Deepak; A K S Rawat; B R Singh
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

10.  Variations in amount of TSST-1 produced by clinical methicillin resistant Staphylococcus aureus (MRSA) isolates and allelic variation in accessory gene regulator (agr) locus.

Authors:  Miki Nagao; Akira Okamoto; Keiko Yamada; Tadao Hasegawa; Yoshinori Hasegawa; Michio Ohta
Journal:  BMC Microbiol       Date:  2009-03-10       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.